Skip to content

A Simple Risk Score for Predicting Acute Kidney Injury Following Immune Checkpoint Inhibitors

A Simple Risk Score for Predicting Acute Kidney Injury Following Immune Checkpoint Inhibitors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126735
Enrollment
Unknown
Registered
2026-06-15
Start date
2026-06-17
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

Malignant Tumor Observation Group:None

Sponsors

The First Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Received immunotherapy with checkpoint inhibitors; 3. Baseline creatinine (SCr) value is available, and there is at least one follow-up data of SCr within 21 days after treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with end-stage renal disease or those undergoing dialysis; 2. Acute kidney injury related to non-immune checkpoint inhibitors (obstructive, infectious kidney diseases, chronic nephritis, nephrotic syndrome, other drug-related nephritis, etc.).

Design outcomes

Primary

MeasureTime frame
Immune checkpoint inhibitor-associated acute kidney injury;

Secondary

MeasureTime frame
Survival time after immune checkpoint inhibitor?associated acute kidney injury;

Countries

China

Contacts

Public ContactLiu Chao

The First Hospital of the Army Medical University

5211715@qq.com+86 23 6876 6170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026